Ana Radeljevic's most recent trade in Merrimack Pharmaceuticals Inc was a trade of 7,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Merrimack Pharmaceuticals Inc | Ana Radeljevic | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 7,000 | 14,000 | - | - | Stock Option (right to buy) | |
Merrimack Pharmaceuticals Inc | Ana Radeljevic | Director | Purchase of securities on an exchange or from another person at price $ 12.03 per share. | 06 Jan 2023 | 4,156 | 4,156 (0%) | 0% | 12.0 | 49,997 | Common Stock |